Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,281.00
Bid: 1,290.00
Ask: 1,292.00
Change: -37.00 (-2.81%)
Spread: 2.00 (0.155%)
Open: 1,312.00
High: 1,318.00
Low: 1,281.00
Prev. Close: 1,318.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 tops 8,000; Centrica is star performer

Thu, 16th Feb 2023 08:49

(Alliance News) - Stock prices in London opened higher on Thursday, with London's blue-chip index pushing past the 8,000 mark once again, a day after it first broke the barrier.

The FTSE 100 index was up 26.04 points, 0.3%, at 8,023.87. It hit a new record high of 8,046.00 points earlier in the morning.

The FTSE 250 was up 50.25 points, 0.3%, at 20,222.84, and the AIM All-Share was up 0.62 of a point, or 0.1%, at 870.15.

The Cboe UK 100 was up 0.3% at 803.05, the Cboe UK 250 flat at 17,564.68, and the Cboe Small Companies up 0.3% at 14,059.05.

The pound was stronger on Thursday morning, though still bruised by UK inflation data on Wednesday that offered the Bank of England room to slow or stop UK interest rate hikes.

Inflation in the UK slowed by slightly more than forecast in January, though remained in double digits, figures from the Office for National Statistics showed. On an annual basis, the consumer price index eased to 10.1% in January from 10.5% in December. Consensus had expected inflation to cool to 10.3%, according to FXStreet.

The pound was quoted at USD1.2053 at early on Thursday in London, higher compared to USD1.2007 at the equities close on Wednesday.

Centrica was the best performing stock in the FTSE 100, up 4.0%.

The British Gas-owner swung to a statutory loss on re-measurement and higher operating costs, while adjusted profit tripled as revenue surged 84%.

The Windsor-based firm announced a pretax loss of GBP240 million in 2022, compared to a profit of GBP954 million in 2021. Revenue jumped 84% to GBP33.64 billion from GBP18.30 billion.

The swing to a loss was on re-measurements after taxation, Centrica said, largely reflecting the revaluation of UK energy supply hedging positions due to wholesale gas and power price falls towards the end of the year. The cost for re-measurement and settlement of derivative energy contracts ballooned to GBP8.48 billion in 2022 from GBP434 million in 2021.

However, adjusted operating profit tripled to GBP3.31 billion from GBP948 million on the revenue rise.

Centrica said it intends to extend its existing GBP250 million buyback programme, announced in November, by an additional GBP300 million. This would result in Centrica buying back 10% of its share capital, the power utility said. The company also proposed a full-year dividend of 2.0 pence, compared to none in 2021.

Relx up 3.0% after it posted double-digit rises in full year profit and revenue. The professional information publisher said it plans to spend GBP800 million on share buybacks in 2023.

In 2022, pretax profit rose 18% to GBP2.11 billion from GBP1.80 billion in 2021, while revenue climbed 18% to GBP8.55 billion from GBP7.24 billion.

Looking ahead, Relx said momentum remains strong across the group. It expects underlying growth rates in revenue and adjusted operating profit to remain above historical trends.

Standard Chartered shares rose 3.1%. The bank reported pretax profit of USD4.29 billion in 2022, up from USD3.35 billion in 2021, as interest income jumped by nearly 50% to USD15.25 billion from USD10.25 billion.

The Asia-focused lender said it was optimistic about the reopening of China and for economic growth in Asia in the year ahead.

In the FTSE 250, Indivior plunged 11%. The pharmaceutical firm swung to a pretax loss of USD95 million in 2022 from a profit of USD190 million the previous year.

Indivior explained that it booked a USD290 million exceptional provision in the year as it navigates initial mediation sessions in late January regarding legacy civil multi-district antitrust litigation.

"Because these matters are in various stages, Indivior cannot predict with any certainty how these matters will ultimately be resolved, or the costs, or timing of such resolution. In particular, any final aggregate costs of these matters, whether resolved by settlement or trial, may be materially different from this provision," the company added.

Elsewhere in London, Coca-Cola Europacific Partners shares slipped 0.2%.

The soft-drinks bottling company reported jumps in pretax profit and revenue in 2022 as it declared a record full-year interim dividend of EUR1.68, up 20% against the prior year.

In 2022, pretax profit totalled EUR1.96 billion, up from EUR1.38 billion the year prior. Revenue climbed to EUR17.32 billion from EUR13.76 billion year-on-year.

Looking forward, Coca-Cola EP said it expects comparable revenue growth of between 6% and 8% in 2023.

In European equities on Thursday, the CAC 40 index in Paris was up 1.0%, while the DAX 40 in Frankfurt was up 0.7%.

European Central Bank President Christine Lagarde reiterated Wednesday that the ECB plans to raise its interest rates by half a percentage point.

Data released on Monday showed the 20-nation currency bloc dodged a recession at the end of last year by posting weak-but-positive growth of 0.1%, while inflation has been easing – even if it remains at a high 8.5%.

"In view of the underlying inflation pressures we intend to raise interest rates by another 50 basis points at our next meeting in March," Lagarde told lawmakers at the European Parliament.

The euro stood at USD1.0713 early Thursday, higher against USD1.0669 at the London equities close on Wednesday. Against the yen, the dollar was trading at JPY133.78, lower compared to JPY134.32.

In Tokyo on Thursday, the Nikkei 225 index closed up 0.7%. In China, the Shanghai Composite closed down 1.0%, while the Hang Seng index in Hong Kong closed up 0.8%. The S&P/ASX 200 in Sydney closed up 0.8%.

New York ended higher on Wednesday, with the Dow Jones Industrial Average ending up 0.1%, the S&P 500 up 0.3%, and the Nasdaq Composite up 0.9%.

Brent oil was quoted at USD85.64 a barrel at early in London on Thursday, up from USD84.07 late Wednesday. Gold was quoted at USD1,840.05 an ounce, sharply higher against USD1,832.19.

The International Energy Agency has sharply raised its forecast for global crude oil demand because of the prospect of stronger economic growth in China.

For the whole year, the IEA expects an increase of 2 million barrels per day to an average of 101.9 million barrels per day.

Still to come on Thursday's economic calendar, the US will publish its weekly unemployment claims report at 1330 GMT alongside the producer price index.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Apr 2023 15:41

UK earnings, trading statements calendar - next 7 days

Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 Mar 2023 17:47

IN BRIEF: Indivior completes acquisition of Opiant Pharmaceuticals

Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and science portfolio through the addition of Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment.

Read more
20 Feb 2023 09:15

LONDON BROKER RATINGS: Berenberg lowers Spectris; RBC cuts Direct Line

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
16 Feb 2023 16:55

LONDON MARKET CLOSE: Records for FTSE and CAC but US PPI hits New York

(Alliance News) - Blue-chip benchmarks in London and Paris hit record highs on Thursday, with the FTSE 100 managing to cling to its daily gain, despite some weakness following US producer price data.

Read more
16 Feb 2023 12:19

CORRECT: LONDON MARKET MIDDAY: FTSE 100 stays above 8,000

(Correcting the GBPUSD quote).

Read more
16 Feb 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 stays above 8,000 as Centrica jumps

(Alliance News) - Stock prices in London were higher at midday on Thursday, with London's flagship index still trading above the 8,000 mark on the back of strong performances from Centrica and Relx.

Read more
16 Feb 2023 10:10

CORRECT: Indivior shares down on swing to annual loss

(Correcting litigation provision is against 2022 results.)

Read more
16 Feb 2023 10:09

TOP NEWS: Indivior shares down on swing to annual loss

(Alliance News) - Indivior PLC on Thursday reported a swing to a full-year loss due to a provision for litigation, despite net revenue jumping by 14% due to growth in its Sublocade injection.

Read more
16 Feb 2023 07:55

LONDON BRIEFING: Centrica, Indivior swing to loss; StanChart bullish

(Alliance News) - Stocks in London were set to open higher on Thursday, with the FTSE 100 called to push past the 8,000 mark again at the open.

Read more
16 Feb 2023 07:54

Indivior shares tumble as group sets aside $290m for US litigation

(Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.

Read more
9 Feb 2023 15:47

UK earnings, trading statements calendar - next 7 days

Friday 10 February 
Ince Group PLCFull Year Results (TBC)
Lancashire Holdings LtdFull Year Results
S&U PLCTrading Statement
Victrex PLCTrading Statement
Monday 13 February 
no events scheduled 
Tuesday 14 February 
Carr's Group PLCFull Year Results
Coca-Cola HBC AGFull Year Results
Plus500 LtdFull Year Results
Tui AGQ1 Results
UP Global Sourcing Holdings PLCTrading Statement
Wednesday 15 February 
Barclays PLCFull Year Results
Brunner Investment Trust PLCFull Year Results
Dunelm Group PLCHalf Year Results
Equipmake Holdings PLCHalf Year Results
Glencore PLCFull Year Results
Hargreaves Lansdown PLCHalf Year Results
Pan African Resources PLCHalf Year Results
Thursday 16 February 
Centrica PLCFull Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Indivior PLCFull Year Results
MJ Gleeson PLCHalf Year Results
Moneysupermarket.com Group PLCFull Year Results
Relx PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
South32 LtdHalf Year Results
Standard Chartered PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
6 Feb 2023 16:32

Indivior announces expiry of waiting period for Opiant purchase

(Alliance News) - Indivior PLC has announced on Monday the expiration of the waiting period relating to its USD145 million purchase of Opiant Pharmaceuticals Inc.

Read more
7 Dec 2022 17:25

LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green

(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe.

Read more
7 Dec 2022 11:44

Indivior targets Nasdaq listing for spring 2023 as hails Sublocade

(Alliance News) - Indivior PLC on Wednesday said it aims to list on the Nasdaq in spring 2023 as it expects its injection Sublocade to reach peak annual net revenue of over USD1.5 billion.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.